A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
| Image |  |
|---|---|
| Description | scientific article published on 18 July 2014 |
| Author/s |
author: Maeve Lowery Eileen M. O'Reilly |
| Publication date | July 18, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |